SEOUL, Jan 12 (Reuters) – South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorizing the use of Novavax Inc’s vaccine on Wednesday and preparing to distribute the first of Pfizer’s antiviral pills. At least 21,000 of Pfizer’s antiviral pills, called Paxlovid, will arrive in…
This post is only available to members.